Yorktown Management & Research Company’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,325
Closed -$233K 237
2025
Q2
$233K Buy
+1,325
New +$199K 0.22% 197
2024
Q4
Sell
-2,800
Closed -$465K 219
2024
Q3
$465K Buy
+2,800
New +$423K 0.48% 85
2023
Q1
Sell
-10,200
Closed -$498K 215
2022
Q4
$498K Hold
10,200
0.61% 49
2022
Q3
$526K Hold
10,200
0.68% 38
2022
Q2
$536K Sell
10,200
-4,300
-30% -$299K 0.69% 40
2022
Q1
$1.25M Hold
14,500
1.06% 15
2021
Q4
$1.19M Hold
14,500
0.8% 18
2021
Q3
$963K Buy
14,500
+500
+4% +$35.5K 0.72% 20
2021
Q2
$938K Buy
14,000
+1,300
+10% +$80.6K 0.74% 21
2021
Q1
$660K Hold
12,700
0.55% 49
2020
Q4
$507K Hold
12,700
0.46% 69
2020
Q3
$311K Buy
12,700
+2,000
+19% +$51.1K 0.29% 188
2020
Q2
$194K Buy
+10,700
New +$211K 0.17% 252

Other funds holding THC

Yorktown Management & Research Company's THC Position: Q3 2025 in Review

Yorktown Management & Research Company sold out of Tenet Healthcare (THC) in Q3 2025, closing a stake of 1,325 shares — an estimated $233K sold.

Yorktown Management & Research Company first reported a position in THC in Q2 2020 and held it in 13 quarters. The position peaked at $1.25M in Q1 2022. 680 funds tracked by Wall St. Rank hold THC as of Q3 2025.

  • Yorktown Management & Research Company reported no remaining Tenet Healthcare position as of Q3 2025 after selling out during the quarter.
  • Yorktown Management & Research Company sold 1,325 Tenet Healthcare shares in Q3 2025, an estimated $233K.
  • Yorktown Management & Research Company first reported a position in Tenet Healthcare in Q2 2020 and held it in 13 quarters.
  • Yorktown Management & Research Company's Tenet Healthcare position peaked at $1.25M in Q1 2022.
  • 680 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2025.

Based on Yorktown Management & Research Company's 13F filing for Q3 2025, filed 29 Oct 2025.